How much does Terconazole Vaginal Cream 0.8% cost?

Pricing for Terconazole Vaginal Cream 0.8% varies by insurance plan, dose, and pharmacy. Our database does not show a fixed cost because prices change faster than we can verify. For current pharmacy prices, check your insurance's formulary tier (in the prior-authorization section), use the GoodRx or Cost Plus Drugs deep links on this page, or ask your pharmacist to run a test claim. If a copay card is listed, it usually drops the out-of-pocket significantly for commercial insurance.

Does Terconazole Vaginal Cream 0.8% need prior authorization?

Terconazole Vaginal Cream 0.8% appears on 1 payer formulary in our database. PA requirements vary by payer — see the prior-authorization table on this page for specifics. In general, specialty and brand-name drugs are more likely to require PA than generic equivalents.

Is there a copay card or patient assistance program for Terconazole Vaginal Cream 0.8%?

We haven't verified an active copay card or PAP for Terconazole Vaginal Cream 0.8% in our current data. Check NeedyMeds or RxAssist for independent directories, or submit what you find via our "Report a broken link" form.

What is Terconazole Vaginal Cream 0.8% used to treat?

Terconazole Vaginal Cream 0.8% is indicated for Yeast Infection, Vaginal Yeast Infection, Candidiasis. Click any condition name on this page for more detail.

Terconazole Vaginal Cream 0.8%

Verified·Apr 23, 2026

Manufacturer: Janssen
NDC: 50090-6299
ICD-10 indication: B37.3

Affordability Check

How much will you actually pay for Terconazole Vaginal Cream 0.8%?

In 30 seconds, see every legitimate way to afford Terconazole Vaginal Cream 0.8% — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Terconazole Vaginal Cream 0.8%

What is this medication? Terconazole vaginal cream 0.8 percent is an antifungal medication used primarily to treat vaginal yeast infections, also known as candidiasis. This condition is caused by an overgrowth of fungi in the vaginal area, which can lead to symptoms like itching, burning, and unusual discharge. By inhibiting the growth of the fungi responsible for the infection, this medication helps to eliminate the cause of the discomfort and restore the natural balance of the vaginal environment. It is important to use this medication exactly as directed by a healthcare professional, usually by inserting it into the vagina with a special applicator once a day at bedtime. Patients should complete the entire course of treatment even if their symptoms disappear after a few days to ensure the infection is fully cleared. Additionally, because this cream may contain oils that can weaken latex products like condoms or diaphragms, it is recommended to use alternative forms of birth control while using this medication.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

Cost Plus Drug Company

Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Terconazole Vaginal Cream 0.8%.

Browse Cost Plus medications →

GoodRx

Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.

Lookup Terconazole Vaginal Cream 0.8% →

NeedyMeds

Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.

Search for Terconazole Vaginal Cream 0.8% →

RxAssist

PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.

Search PAPs →

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Terconazole Vaginal Cream 0.8%. Official source: DailyMed (NLM) · Label effective Jan 3, 2023

Indications and usage

INDICATIONS AND USAGE Terconazole vaginal cream 0.8% is indicated for the local treatment of vulvovaginal candidiasis (moniliasis). As terconazole vaginal cream 0.8% is effective only for vulvovaginitis caused by the genus Candida, the diagnosis should be confirmed by KOH smears and/or cultures.

Dosage and administration

DOSAGE AND ADMINISTRATION One full applicatorful (5 g) of terconazole vaginal cream 0.8% (40 mg terconazole) should be administered intravaginally once daily at bedtime for three consecutive days. Before prescribing another course of therapy, the diagnosis should be reconfirmed by smears and/or cultures and other pathogens commonly associated with vulvovaginitis ruled out. The therapeutic effect of terconazole vaginal cream 0.8% is not affected by menstruation.

Contraindications

CONTRAINDICATIONS Patients known to be hypersensitive to terconazole or to any of the components of the cream.

Warnings

WARNINGS None.

Drug interactions

Drug Interactions: The therapeutic effect of this product is not affected by oral contraceptive usage.

Adverse reactions

ADVERSE REACTIONS During controlled clinical studies conducted in the United States, patients with vulvovaginal candidiasis were treated with terconazole vaginal cream 0.8% for 3 days. Based on comparative analyses with placebo and a standard agent, the adverse experiences considered most likely related to terconazole vaginal cream 0.8% were headache (21% vs 16% with placebo) and dysmenorrhea (6% vs 2% with placebo). Genital complaints in general, and burning and itching in particular, occurred less frequently in the terconazole vaginal cream 0.8% 3 day regimen (5% vs. 6%-9% with placebo). Other adverse experiences reported with terconazole vaginal cream 0.8% were abdominal pain (3.4% vs. 1% with placebo) and fever (1% vs. 0.3% with placebo). The therapy-related dropout rate was 2.0% for the terconazole vaginal cream 0.8%. The adverse drug experience most frequently causing discontinuation of therapy was vulvovaginal itching, 0.7% with the terconazole vaginal cream 0.8% group and 0.3% with the placebo group.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

Payer	PA	Step therapy	Copay tier
— Medicare Part D	—	—	—

Payer

Step therapy

Copay tier

—

Medicare Part D

—

Related drugs

How this page is sourced

Drug identity verified against openFDA NDC Directory.
Label text (when shown) originates from NLM DailyMed.
Copay and assistance URLs verified periodically; if you hit a broken link, tell us.